Keyword: Elijah Cummings

A bipartisan push to lower drug prices could threaten the industry's ability to drive earnings growth, some analysts warn.

Vermont lawmakers took it upon themselves to pass a bill allowing drug imports from Canada. The catch? It'll need an OK from the Trump administration.

President Donald Trump's big speech on drug prices is set for Friday, but Democrats talked up their own proposals Thursday.

Even though drug pricing talk in Washington, D.C., has quieted somewhat, a group of lawmakers continue to beat the drum for reform.

Lawmakers in the House are kicking off an investigation of Allergan's tribal licensing deal to protect Restasis.

Rep. Elijah Cummings, D-Md., is urging President Trump to press for lower prices on Biogen's multiple sclerosis drug Zinbryta.

Lawmakers in California have approved a pricing transparency bill strongly opposed by PhRMA, sending it to Gov. Jerry Brown for a decision.

Reps. Elijah Cummings and Peter Welch announced a new probe into multiple sclerosis drug costs, digging into price hikes from seven pharmas.

Scott Gottlieb said his FDA would speed generics to market, and that effort boasts an early branded victim: Valeant’s controversial heart med Isuprel.

PTC says it'll charge $35,000 for Emflaza, the Duchenne drug it bought from Marathon in March, amid a brouhaha over its $89,000 list price. Is the new sticker low enough?